Treatment of peri-implant defects with combination growth factor cement

Journal of Periodontology

Volumn 71, Issue 1, 2000, Pages 8-13

  Meraw, Stephen J ^b,c   Reeve, Charles M ^d   Lohse, Christine M ^d   Sioussat, Tracy M ^a  

^a Tissue Engineering Inc   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c MAYO CLINIC   (United States)

^d NONE

Author keywords

Dental implants; Growth factors, basic fibroblast; Growth factors, platelet derived; Growth factors, transforming; Guided bone regeneration

Indexed keywords

ALPHA TRICALCIUM PHOSPHATE; ALPHA-TRICALCIUM PHOSPHATE; BONE CEMENT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE MONOBASIC; COLLAGEN; COLORING AGENT; DIAGNOSTIC AGENT; DICALCIUM PHOSPHATE ANHYDROUS; FIBROBLAST GROWTH FACTOR 2; GROWTH PROMOTOR; PLATELET DERIVED GROWTH FACTOR; TETRACALCIUM PHOSPHATE; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; BIODEGRADABLE IMPLANT; BONE REGENERATION; COMPARATIVE STUDY; DOG; FEASIBILITY STUDY; FOLLOW UP; IMAGE PROCESSING; MALE; OSTEOLYSIS; PERIODONTICS; PREMOLAR TOOTH; RANDOMIZATION; TOOTH IMPLANTATION;

ABSORBABLE IMPLANTS; ALVEOLAR BONE LOSS; ANIMALS; BICUSPID; BONE CEMENTS; BONE MORPHOGENETIC PROTEINS; CALCIUM PHOSPHATES; COLLAGEN; COLORING AGENTS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DOGS; FEASIBILITY STUDIES; FIBROBLAST GROWTH FACTOR 2; FOLLOW-UP STUDIES; GROWTH SUBSTANCES; GUIDED TISSUE REGENERATION, PERIODONTAL; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MEMBRANES, ARTIFICIAL; OSSEOINTEGRATION; PLATELET-DERIVED GROWTH FACTOR; RANDOM ALLOCATION; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033628499     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.71.1.8     Document Type: Article

References (42)

1. Meraw SJ, Reeve CM, Wollan PC. Use of alendronate in peri-implant defect regeneration. J Periodontol 1999; 70:151-158.
2. Rutherford RB, Sampath TK, Rueger DC, Taylor TD. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int J Oral Maxillofac Implants 1992;7:297-301.
3. Becker W, Lynch SE, Lekholm U, et al. A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like growth factor-I or demineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants. J Periodontol 1992;63:929-940.
4. Lynch SE, Buser D, Hernandez RA, et al. Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol 1991;62:710-716.
5. Xiang W, Baolin L, Yan J, Yang X. The effect of bone morphogenetic protein on osseointegration of titanium implants. J Oral Maxillofac Surg 1993;51:647-651.
6. Xiang W, Yan J, Baolin L, et al. Tissue reactions to titanium implants containing bovine bone morphogenetic protein: A scanning electron microscopic investigation. Int J Oral Maxillofac Surg 1994;23:115-119.
7. The American Academy of Periodontology. The potential role of growth and differentiation factors in periodontal regeneration (position paper). J Periodontol 1996;67:545-553.
8. Carpenter G, Cohen S. Human epidermal growth factor and the proliferation of human fibroblasts. J Cell Physiol 1975;88:227-238.
9. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. Type β transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci (USA) 1985;82:119-123.
10. Gospodarowicz D, Moran JS, Braun DL. Control of proliferation of bovine vascular endothelial cells. J Cell Physiol 1977;91:377-386.
11. Deul TF, Senior RM, Huang JS, Griffin GL. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 1982;69:1046-1049.
12. Seppa H, Grotendorst G, Seppa S, Schiffman E, Martin GR. Platelet-derived growth factor is chemotactic for fibroblasts. J Cell Biol 1982;92:584-588.
13. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci (USA) 1987;84:5788-5792.
14. Chua CC, Geiman DE, Keller GH, Ladda RL. Induction of collagenase secretion in human fibroblasts by growth promoting factors. J Biol Chem 1985;260:5213-5216.
15. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci (USA) 1986;83:4167-4171.
16. Savage K, Siebert E, Swann D. The effect of platelet-derived growth factor on cell division and glycosamino-glycan synthesis by skin and scar fibroblasts. J Invest Dermatol 1987;89:93-99.
17. Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc Natl Acad Sci (USA) 1987;84:7696-7700.
18. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989; 84:640-646.
19. Greenhalgh DG, Hummel RP III, Albertson S, Breeden MP. Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo. Enhancement of tissue repair in genetically diabetic mice. Wound Rep Reg 1993;1:69-81.
20. Knighton DR, Fiegel VD, Austin LL, Ciresi KF, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986;204:322-329.
21. Heikinheimo K. Stage-specific expression of decapentaplegic-Vg-related genes 2, 4, and 6 (bone morphogenetic proteins 2, 4, and 6) during human tooth morphogenesis. J Dent Res 1994;73:590-597.
22. Jones CM, Lyons KM, Hogan BL. Involvement of bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 1991;111:531-542.
23. Lyons KM, Pelton RW, Hogan BL. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein 2A (BMP-2A). Development 1990;109:833-844.
24. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Arch Otolaryngol Head Neck Surg 1991;17:1101-1112.
25. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjo UME. Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995; 66:131-138.
26. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997;17:125-139.
27. Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science 1983;220:680-686.
28. Dennison DK, Vallone DR, Pinero GJ, Rittman B, Caffesse RG. Differential effect of TGF-β1 and PDGF on proliferation of periodontal ligament cells and gingival fibroblasts. J Periodontol 1994;65:641-648.
29. Centrella M, McCarthy TL, Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 1987;262:2869-2874.
30. Keski-Oja J, Raghow R, Sawdy M, et al. Regulation of the mRNAs for type I plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-xβ. Divergent responses in lung fibroblasts and carcinoma cells. J Biol Chem 1988;263:3111-3115.
31. Wrana JL, Macho M, Hawrylyshyn B, Yao KL, Domenicucci C, Sodek J. Differential effects of transforming growth factor-β on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 1988;106:915-924.
32. Terranova VP, Odziemiec C, Tweden KS, Spadone DP. Repopulation of dentin surfaces by periodontal ligament cells and endothelial cells: Effect of basic fibroblast growth factor. J Periodontol 1989;60:293-301.
33. Canalis E, McCarthy T, Centrella M. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 1988;81:1572-1577.
34. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-447.
35. Howes R, Bowness JM, Grotendorst GM, Marting GR, Reddi AH. Platelet-derived growth factor enhances demineralized bone matrix-inducing cartilage and bone formation. Calcif Tissue Int 1988;42:34-38.
36. Hughes FJ, Aubin JE, Heersche JN. Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta. Bone Miner 1992;19:63-74.
37. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 1994;15:203-208.
38. Giannobile WV, Whitson SW, Lynch SE. Synergistic effects of insulin-like growth factor-I (IGF-I) with other growth factors on bone formation in vitro. J Dent Res 1994;73(Spec. Issue):205(Abstr. 831).
39. Hurley LA, Stinchfield FE, Bassett AL, Lyon WH. The role of soft tissues in osteogenesis: An experimental study of canine spine fusions. J Bone Joint Surg 1959;41A:1243-1254.
40. Brånemark PI. Osseointegration and its experimental background. J Prosthet Dent 1983;50:399-410.
41. Albrektsson T, Jansson T, Lekholm U. Osseointegrated dental implants. Dent Clin North Am 1986;30:151-174.
42. Adell R. Long-term treatment results. In: Brånemark PI, Zarb GA, Albrektsson T, eds. Tissue-Integrated Prostheses. Osseointegration in Clinical Dentistry. Chicago: Quintessence Publishing Company; 1985:10.